Προωθημένο
North America and Europe Lead the AI in Drug Discovery Market, Supported by Robust Biopharma R&D and Regulatory Acceptance of AI Models
The AI in drug discovery market size was valued at USD 1.99 billion in 2024. The market is projected to grow from USD 2.65 billion in 2025 to USD 35.42 billion by 2034, exhibiting a CAGR of 29.6% during 2025–2034. This extraordinary growth trajectory reflects a fundamental reconfiguration of pharmaceutical R&D, where artificial intelligence is no longer experimental but instrumental...
0 Σχόλια 0 Μοιράστηκε 32 Views 0 Προεπισκόπηση